Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert

Seeking Alpha

Immunomedics, Inc. (IMMU)

()

News & PR
Market Currents

Buzz
Twitter: IMMU

Business Intelligence
Transcripts
Events
Key Developments


	52wk high:
	52wk low:
	EPS:
	PE:
	Dividend:
	Yield:
	Market Cap:
	Exchange:

Analysis - Latest Articles

Trial Results Bode Well for Human Genome Sciences

EP Vantage • Nov 02 • Comment!
Weekly Street Sentiment: Market Prepares for ‘Trick or Treat’

First Coverage • Oct 27 • Comment!
Immunomedics Gets a Lot of Things Right

EP Vantage • Oct 03 • Comment!
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers

Justin M. Hall • Sep 20 • 3 Comments
Biotech Busy with Bevy of Small Deals

The Burrill Report • Sep 12 • 1 Comment
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up

Justin M. Hall • Sep 11 • 23 Comments

More articles on IMMU »

Instablogs

FIRST COVERAGE WEEKLY SENTIMENT (October 27, 2009): Market Prepares for ‘Trick or Treat.’

Mon October 26, 2009 • First Coverage • Comment!
Spectrum Pharmaceuticals: $50 Million Vote of Confidence or Cause for Concern

Fri September 18, 2009 • Justin M. Hall • 15 Comments
Spectrum Pharmaceuticals: Post Zevalin Approval Sales Should Ramp Up

Fri September 11, 2009 • Justin M. Hall • 10 Comments

Write a post on IMMU | More Instablogs on IMMU »

Sentiment

What advice would you give to
IMMU?

What's your view of IMMU?

Make sure you include IMMU